Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence
- 9 May 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 21 (7) , 1019-1029
Abstract
Introduction: Both alcohol and benzodiazepine dependence (AD, BD) are severe and chronic conditions with devastating physical and mental health effects. The relative scarcity and controversial evidential status of available pharmacological interventions for the treatment of patients' acute withdrawal syndrome and/or relapse prevention call for the clinical investigation of novel safe and efficacious agents. Areas covered: We review published studies of pregabalin as monotherapy in the treatment of AD and BD in more than 450 patients. Available evidence includes four RCTs, two in AD with active comparator drugs (naltrexone, tiapride, and lorazepam) and one placebo-controlled, and one placebo-controlled in BD. We also review other available studies on pregabalin's potential to reduce benzodiazepine consumption, its side effects, especially cognitive, as well as extant reports on its liability for abuse. Expert opinion: Available evidence suggests that monotherapy with pregabalin, within the dosage range of ...Keywords
This publication has 54 references indexed in Scilit:
- Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utilityTherapeutics and Clinical Risk Management, 2012
- Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteersPharmacology Biochemistry and Behavior, 2012
- Opioid modulators for alcohol dependenceExpert Opinion on Investigational Drugs, 2011
- Pregabalin Influences Insula and Amygdala Activation During Anticipation of Emotional ImagesNeuropsychopharmacology, 2011
- The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trialsEpilepsia, 2011
- Nalmefene for treatment of alcohol dependenceExpert Opinion on Investigational Drugs, 2010
- Feeling anxious: anticipatory amygdalo-insular response predicts the feeling of anxious anticipationSocial Cognitive and Affective Neuroscience, 2010
- Metabolic Considerations in a Case of Pregabalin-induced EdemaPharmacopsychiatry, 2009
- Prediction of Serotonergic Treatment Efficacy Using Age of Onset and Type A/B Typologies of AlcoholismAlcohol, Clinical and Experimental Research, 2008
- Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trialCurrent Medical Research and Opinion, 2005